{
  "source_file": "2_2-4-Isobutylphenylpropionic_Acid_Ibuprofen.json",
  "model": "qwen",
  "image_used_for_q1": true,
  "answers": [
    {
      "question": "Look at the molecular structure diagram in the image. What chemical compound is shown, and what are its key properties?",
      "answer": "The molecular structure diagram in the image shows **2-(4-isobutylphenyl)propionic acid**.\n\n### Key Properties of 2-(4-isobutylphenyl)propionic Acid:\n1. **Molecular Formula**: The molecular formula indicates the presence of carbon (C), hydrogen (H), and oxygen (O) atoms in the molecule.\n2. **Isobutyl Phenyl Group**: The isobutyl phenyl group is attached to the propionic acid moiety. This group makes the molecule hydrophobic, which might influence its solubility and biological activity.\n3. **Propionic Acid Group**: The propionic acid group has a carboxylic acid functionality which is prone to ionization, making it slightly acidic in nature.\n4. **Stereochemistry**: Depending on the specific configuration of the isobutylphenyl group, the molecule might exhibit different stereoisomers, each with potentially different biological activities.\n5. **Potential Uses**: This compound is often used in pharmaceuticals and as a precursor in the synthesis of other organic molecules. Its properties suggest it could be used as an anti-inflammatory or analgesic, similar to ibuprofen, which is a derivative of this compound.\n\nThe molecular structure diagram is a visual representation of the arrangement of atoms within the molecule, indicated by the colors and bonds. The red spheres represent oxygen atoms, the white spheres represent hydrogen atoms, and the black spheres represent carbon atoms. The gray and striped bonds represent single and double bonds, respectively.",
      "latency_s": 10.06
    },
    {
      "question": "What is the chemical formula and molecular weight of 2-(4-Isobutylphenyl)propionic acid?",
      "answer": "The chemical formula for 2-(4-Isobutylphenyl)propionic acid is:\n\n\\[ \\text{C}_{14}\\text{H}_{20}\\text{O}_{2} \\]\n\n### Steps to determine the molecular weight:\n1. **Identify the atomic weights of each element:**\n   - Carbon (\\(\\text{C}\\)): 12.01 g/mol\n   - Hydrogen (\\(\\text{H}\\)): 1.008 g/mol\n   - Oxygen (\\(\\text{O}\\)): 16.00 g/mol\n\n2. **Calculate the total weight for each element in the formula:**\n   - Carbon (\\(\\text{C}\\)): \\(14 \\times 12.01 = 168.14 \\text{ g/mol}\\)\n   - Hydrogen (\\(\\text{H}\\)): \\(20 \\times 1.008 = 20.16 \\text{ g/mol}\\)\n   - Oxygen (\\(\\text{O}\\)): \\(2 \\times 16.00 = 32.00 \\text{ g/mol}\\)\n\n3. **Sum up the weights:**\n   \\[\n   \\text{Molecular Weight} = 168.14 + 20.16 + 32.00 = 220.30 \\text{ g/mol}\n   \\]\n\nSo, the molecular weight of 2-(4-Isobutylphenyl)propionic acid is **220.30 g/mol**.",
      "latency_s": 8.8
    },
    {
      "question": "Why was 2-(4-Isobutylphenyl)propionic acid, also known as ibuprofen, developed as an analgesic and anti-inflammatory medication?",
      "answer": "2-(4-Isobutylphenyl)propionic acid, also known as ibuprofen, was developed as an analgesic and anti-inflammatory medication due to its unique structure and pharmacological properties. Ibuprofen belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs work by inhibiting the activity of cyclooxygenase enzymes (COX), which are responsible for the production of prostaglandins. Prostaglandins are known to play a role in the inflammatory process and pain signaling.\n\nIbuprofen, in particular, was synthesized in the 1960s in the laboratory of Alexander Fixmer, who was searching for effective NSAIDs. The molecule's structure was designed to target and inhibit the COX enzymes, thus blocking the production of prostaglandins. This mechanism makes ibuprofen effective in reducing pain, inflammation, and fever.\n\nThe specific structure of ibuprofen allows it to interact with the COX enzymes in a way that leads to a high degree of selectivity over other related enzymes. This selectivity is what makes ibuprofen effective for its intended use, while reducing the potential side effects associated with other NSAIDs.\n\nThe development of ibuprofen was a result of several years of research and testing in the laboratory and on test animals, which ultimately led to its approval for use as a medication in 1962 in the UK and 1969 in the US. Since then, ibuprofen has been widely used to treat various conditions such as headaches, muscle aches, arthritis, and menstrual cramps due to its effectiveness in providing rapid and effective pain relief and reducing inflammation.",
      "latency_s": 8.8
    },
    {
      "question": "Given that 2-(4-Isobutylphenyl)propionic acid decomposes above its melting point, what implications does this have for its storage and use in pharmaceutical applications?",
      "answer": "The fact that 2-(4-Isobutylphenyl)propionic acid decomposes above its melting point has several important implications for its storage and use in pharmaceutical applications:\n\n1. **Storage Requirements**:\n   - It should be stored below its melting point to prevent decomposition. This ensures that the compound maintains its desired properties and efficacy.\n   - The storage temperature must be carefully controlled to prevent the material from melting and then undergoing decomposition. This could involve storing it in a refrigerator or freezer, depending on its melting point.\n\n2. **Handling Precautions**:\n   - When handling the compound, care should be taken to ensure that it remains solid at the working temperature. If it starts to melt, it should be immediately re-cooled to prevent decomposition.\n   - Proper storage containers that prevent melting and exposure to air or light should be used to minimize the risk of decomposition.\n\n3. **Stability during Use**:\n   - In pharmaceutical applications, the compound should be used as soon as possible after being taken out of its storage container to prevent any decomposition that could occur during the process.\n   - It is crucial to ensure that the working environment does not exceed the melting point of the compound, which could lead to decomposition and subsequent loss of efficacy.\n\n4. **Quality Control**:\n   - Regular quality control checks should be performed to monitor the stability of the compound, especially as it relates to its melting point. This includes periodic tests to ensure that no decomposition has occurred in storage or during use.\n\n5. **Formulation and Dosage**:\n   - Formulation processes must be designed to ensure that the compound remains in a solid state throughout the process, avoiding any melting that could lead to decomposition.\n   - Dosage forms should be designed to release the compound at a controlled rate to avoid exposure to temperatures that could cause decomposition.\n\nIn summary, the storage and use of 2-(4-Isobutylphenyl)propionic acid must be carefully managed to prevent decomposition above its melting point. This includes maintaining the compound's solid state, ensuring appropriate storage conditions, and monitoring its stability throughout its lifecycle in pharmaceutical applications.",
      "latency_s": 8.8
    }
  ],
  "regenerated_at": "2025-11-23 00:05:55",
  "regenerated_with": "vllm",
  "max_tokens": 500
}